John M. Oldham, MD, MS

Senior vice president and chief of staff, The Menninger Clinic; professor of psychiatry and executive vice chair, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas

Borderline Personality Disorder: Overview of Recent Research Findings

Presenter: John M. Oldham, MD, MS

Senior vice president and chief of staff, The Menninger Clinic; professor of psychiatry and executive vice chair, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas

Objectives

1. Recognize current research findings regarding the etiology and neurobiology of borderline personality disorder (BPD).

2. Describe evidence-based recommendations for treatment of patients with BPD.

3. Identify longitudinal studies of BPD that support new ways of categorizing and defining the disorder, which will guide the DSM-V planning process.

Mentalizing in the Treatment of BPD

Presenter: Jon G. Allen, PhD

Director of psychology, The Menninger Clinic; professor of psychiatry and Helen Malsin Palley Chair in Mental Health Research, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas

Objectives

1. Explain how attachment relationships influence mentalizing development.

2. Discuss the basic principles of mentalizing-focused, BPD treatment.

Presenter: Glen O. Gabbard, MD

Brown Foundation Chair of Psychoanalysis and professor of psychiatry, Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine; director, Baylor Psychiatric Clinic, Houston, Texas

Objectives

1. Discuss the research base for use of medications in BPD treatment.

2. Contrast the types of psychotherapy that have been shown to be efficacious with patients who have BPD.

Presenter: Perry D. Hoffman, PhD

President, National Education Alliance for Borderline Personality Disorder, Rye, New York

Objectives

1. Acknowledge the impact of BPD on family members.

2. Identify the role of family psychoeducation for relatives of persons with BPD.

3. Describe specific skills to increase family members’ coping strategies.

Presenter: Donna S. Bender, PhD

Research director, Institute for Mental Health Research, Phoenix, Arizona; research associate professor of psychiatry, Department of Psychiatry, University of Arizona, Tucson, Arizona

Objectives

1. Identify the role of mental representations of self and others in the context of BPD.

2. Consider treatment implications of a self-other representational model of BPD.

Presenter: Larry J. Siever, MD

Professor of psychiatry, Department of Psychiatry, Mount Sinai School of Medicine, New York, New York; director, Mental Illness Research, Education and Clinical Center (MIRECC), Bronx VA Medical Center, Bronx, New York, New York

Objectives

1. Recognize that BPDs have neurobiologic substrates.

2. Acknowledge that these substrates provide a rationale for pharmacotherapy.

3. Accept that the neurobiology of BPDs has implications for psychosocial treatment.

Presenter: Andrew E. Skodol, MD

President, Institute for Mental Health Research, Phoenix, Arizona; research professor of psychiatry, Department of Psychiatry, University of Arizona College of Medicine, Tucson, Arizona

Objectives

1. Describe the goals for the DSM-V and the process of revision.

2. Explain how BPD might be described and diagnosed according to alternative models being considered for DSM-V psychiatric diagnoses.